Beyer E, Schono N, Kozlova I, Wiederschain G
Institute of Biological and Medical Chemistry, U.S.S.R. Academy of Medical Sciences, Moscow.
Biochim Biophys Acta. 1990 May 8;1038(3):386-9. doi: 10.1016/0167-4838(90)90253-c.
Activities and multiple forms of alpha-D-galactosidase of human kidney and liver in the normal and in Fabry's disease were comparatively studied using alpha-D-galactoside and alpha-D-fucoside as substrates. By isoelectric focusing alpha-D-galactosidase was shown to exist in multiple forms, one of which possesses both alpha-D-galactosidase and alpha-D-fucosidase activity. In Fabry's disease, caused by a deficiency of alpha-D-galactosidase A, we found only one form of alpha-D-galactosidase, which corresponded to form B (alpha-N-acetylgalactosaminidase) and was also able to split alpha-D-fucoside. Thus, in Fabry's disease the alpha-D-fucosidase profile was virtually unchanged, as compared with the normal. The results obtained indicate that the alpha-D-fucosidase activity is due to the action of alpha-D-galactosidase B, encoded for by an autosomal gene of chromosome 22. We suppose these data could be confirmed by revealing the significant reduction of the alpha-D-fucosidase activity in patients with alpha-N-acetylgalactosaminidase deficiency.
以α-D-半乳糖苷和α-D-岩藻糖苷为底物,对正常人和法布里病患者肾脏和肝脏中的α-D-半乳糖苷酶活性及多种形式进行了比较研究。通过等电聚焦显示α-D-半乳糖苷酶以多种形式存在,其中一种同时具有α-D-半乳糖苷酶和α-D-岩藻糖苷酶活性。在由α-D-半乳糖苷酶A缺乏引起的法布里病中,我们仅发现一种α-D-半乳糖苷酶形式,它对应于B型(α-N-乙酰半乳糖胺酶),并且也能够分解α-D-岩藻糖苷。因此,与正常情况相比,法布里病中的α-D-岩藻糖苷酶谱实际上没有变化。所得结果表明,α-D-岩藻糖苷酶活性是由位于22号染色体上的常染色体基因编码的α-D-半乳糖苷酶B的作用所致。我们推测,通过揭示α-N-乙酰半乳糖胺酶缺乏患者中α-D-岩藻糖苷酶活性的显著降低,这些数据可能会得到证实。